Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 11/27/2025Olymvax Files for Hong Kong Listing as Vaccine Pipeline Expands
  • 11/27/2025GlobalData: Ivonescimab Poised to Transform China's TNBC Market
  • 11/27/2025Novartis's Rhapsido Approved for Chronic Spontaneous Urticaria in Chin...
  • 11/27/2025Ascentage Pharma Publishes Phase Ib Data for Olverembatinib in GIST
  • 11/27/2025NMPA Approves AstraZeneca's Imfinzi for NSCLC in China
  • 11/27/2025Biontech to Present Phase 2 Data for Bispecific Antibody Pumitamig in ...
  • 11/27/2025CSPC's JMT206 Wins Green Light for First-in-Human Trials in China
  • 11/27/2025Sugemalimab Wins European Approval for Stage III NSCLC
  • 11/25/2025China Accelerates Investment in Nuclear Medicine Amid Global Radiophar...
  • 11/25/2025Kelun Reports Positive Phase 2 Results for Sac-TMT Combined with KEYTR...
  • 11/25/2025CDE Solicits Comments on Draft Guidance for Computerized Systems and E...
  • 11/25/2025Samsung LS Fund Invests in Phrontline to Boost ADC Development
  • 11/25/2025Amicus Diversifies Manufacturing from China to Reduce Geopolitical Ris...
  • 11/25/2025Former NMPA Deputy Head Prosecuted for Bribery
  • 11/25/2025BioCorteX and CD Biopharma Form Strategic Alliance to Accelerate Preci...
  • 11/25/2025Luye Pharma Receives FDA IND Clearance for LY03017
  • 11/25/2025Huaota Reports Pivotal Phase 3 Success for HB0017
  • 11/25/2025Pfizer's Hympavzi (Marstacimab) Gains NMPA Approval in China
  • 11/25/2025Phrontline Raises $60M in Pre-A+ Round to Accelerate Bispecific and D...
  • 11/25/2025Oralead Secures CNY 100M in Series A to Advance Oral Biologics
  • 11/25/2025Reprogenix Raises CNY 500M in A+ Round to Push Forward First-In-China...
  • 11/21/2025Recent Executive Moves
  • 11/21/2025NMPA Issues New Rules on Inspections and Export Certificates for Drug ...
  • 11/21/2025CSPC Advances Nectin-4 ADC SYS6002 Into First Phase 3 Trial
  • 11/21/2025RocRock Biotech Raises CNY 50M to Advance Next-Gen CAR-M Therapies
  • 11/21/2025Lynk Reports Positive Phase II Results for Topical JAK Inhibitor
  • 11/21/2025Xiangxue Expands Into In Vivo TCR-T Therapy Through New Partnership
  • 11/21/2025Innovent Moves Toward China Filing After High-Dose Obesity Drug Delive...
  • 11/20/2025Innovent's Mazdutide Achieves Strong Phase 3 Results in Chinese Obesit...
  • 11/20/2025GSK, LTZ Forge Strategic Alliance to Advance Novel Myeloid Cell Engage...
  • Page:1/59 Total number of articles:1742: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group